Antony Mattessich
Directeur/Membre du Conseil chez AURA BIOSCIENCES, INC.
Fortune : 987 076 $ au 30/04/2024
Postes actifs de Antony Mattessich
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AURA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 29/09/2021 | - |
| Independent Dir/Board Member | 29/09/2021 | - |
Historique de carrière de Antony Mattessich
Anciens postes connus de Antony Mattessich
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC. | Directeur/Membre du Conseil | 01/06/2017 | 15/04/2024 |
| Directeur Général | 01/08/2017 | 15/04/2024 | |
| President | 26/07/2017 | 15/04/2024 | |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 01/08/2017 | 18/12/2017 |
| Directeur Général | 01/08/2017 | 18/12/2017 | |
| Corporate Officer/Principal | 01/01/2009 | 01/08/2017 | |
| President | 01/08/2017 | 18/12/2017 | |
Napp Pharmaceutical Holdings Ltd.
 Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2005 | 01/05/2011 |
| Directeur Général | 01/01/2005 | 01/05/2011 | |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2003 | 01/01/2005 |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur/Membre du Conseil | - | - |
Formation de Antony Mattessich
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Royaume-Uni | 3 |
| Suisse | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| AURA BIOSCIENCES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
Napp Pharmaceutical Holdings Ltd.
Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Antony Mattessich
- Expérience
